Equity Profile

GMED

Globus Medical, Inc.

Health CareHealth Care Equipment$11.5B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Globus Medical, Inc. (GMED) operates in the health care sector, focusing on developing innovative medical devices for spinal surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's market demand and overall business health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Globus Medical, Inc. (GMED) operates in the health care sector, focusing on developing innovative medical devices for spinal surgery. The company plays a vital role in the growing health care equipment industry, which is increasingly driven by advancements in technology and an aging population requiring surgical solutions.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

In Q1-2026, Globus Medical reported an EPS of $1.12, exceeding analyst expectations by 22%. However, the stock fell 4.65% the following day, indicating mixed investor sentiment despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations are mixed as the company has a strong track record of beating earnings estimates, but recent stock performance suggests caution among investors. The upcoming earnings report will be closely watched for any signs of sustained growth.

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or margin pressure could raise concerns about the company's growth trajectory and lead to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be crucial for gauging ongoing profitability and investor confidence.

How is revenue growth trending in key markets?

Understanding revenue growth in critical segments will help investors assess the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth in emerging markets, which could offset any domestic challenges.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational performance than anticipated.

Options pricing suggests a significant move, reflecting investor uncertainty that may not align with the company's growth potential.

Key Risk

If revenue growth exceeds expectations, it could invalidate current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether the company can maintain its growth trajectory and profitability in a competitive market.

Bull Confirmed If

An EPS of $1.20 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.00 would raise concerns about profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating that investors are expecting volatility.

Options price a 16.79% move but the stock has averaged only 1.66% over the last 8 quarters — setup is rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.6%, with a raw directional average of +2.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GMED beats expectations, history suggests the stock could rise by an average of 1.66%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management commentary.

Miss

If the company misses expectations, history suggests a potential decline of around 1.33%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth in emerging markets.
2Management's commentary on cost management and gross margin expectations.
3Insights into new product launches and their anticipated impact on sales.
4Details on competitive pressures and market share developments.
5Any changes in guidance for the remainder of the fiscal year.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Globus Medical, Inc. (GMED) operates in the health care sector, focusing on developing innovative medical devices for spinal surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well the company is managing costs and generating income.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's market demand and overall business health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining revenue or margin pressure could raise concerns about the company's growth trajectory and lead to further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given the company's history of beating EPS estimates, this figure will be crucial for gauging ongoing profitability and investor confidence.

How is revenue growth trending in key markets?

Understanding revenue growth in critical segments will help investors assess the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth in emerging markets, which could offset any domestic challenges.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating stronger operational performance than anticipated.

Options pricing suggests a significant move, reflecting investor uncertainty that may not align with the company's growth potential.

Key Risk

If revenue growth exceeds expectations, it could invalidate current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core thesis revolves around whether the company can maintain its growth trajectory and profitability in a competitive market.

Bull Confirmed If

An EPS of $1.20 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.00 would raise concerns about profitability and growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a significant move following the earnings report, indicating that investors are expecting volatility.

Options price a 16.79% move but the stock has averaged only 1.66% over the last 8 quarters — setup is rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GMED beats expectations, history suggests the stock could rise by an average of 1.66%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management commentary.

Miss

If the company misses expectations, history suggests a potential decline of around 1.33%, raising concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth in emerging markets.
2Management's commentary on cost management and gross margin expectations.
3Insights into new product launches and their anticipated impact on sales.
4Details on competitive pressures and market share developments.
5Any changes in guidance for the remainder of the fiscal year.